Nine rhesus macaques (Macaca mulatta) were inoculated with a combinati
on of two passaged strains of SIVmac (R71 and 17E), both of which are
known to be neurovirulent. Auditory brainstem responses (ABRs) were re
corded at regular intervals from these animals both before and after i
noculation. Increases in ABR peak and interpeak latency were observed
corresponding to progression of SIV disease. Post-inoculation increase
s in latency were observed for all five peaks of the ABR and for inter
peak intervals I-V and III-V, The largest increases in latency were as
sociated with end-stage disease. Within 14 weeks of inoculation, all b
ut two animals developed end-stage simian AIDS and were euthanized. Hi
stopathological examination revealed multifocal lesions in the cerebra
l gray and white matter as well as in the auditory structures of the b
rainstem. In most animals, ABR changes were accompanied by evidence of
underlying neuropathology. However, cases of severe neuropathology wi
th no ABR abnormalities and vice versa were also noted. Though in a mu
ch shorter time frame, SIVmac R71/17E produced both physiological and
histopathological abnormalities similar to those associated with HIV d
isease in humans. These results further support the SIVmac R71/17E inf
ected rhesus macaque as an animal model of HIV related neurological di
sease in humans.